Similar articles

• Coming of age: anti-cytokine therapies.

  Song XY, Torphy TJ, Griswold DE, Shealy D. Song XY, et al. Mol Interv. 2002 Feb;2(1):36-46. doi: 10.1124/mi.2.1.36. Mol Interv. 2002. PMID: 14993360 Review.
• Cytokines in cytotherapy.

  Saenger Y, Wolchok J. Saenger Y, et al. Cytotherapy. 2006;8(4):313-4. doi: 10.1080/14653240600861226. Cytotherapy. 2006. PMID: 16923605 No abstract available.
• Mechanisms for modulating TNF alpha in immune and inflammatory disease.

  Baugh JA, Bucala R. Baugh JA, et al. Curr Opin Drug Discov Devel. 2001 Sep;4(5):635-50. Curr Opin Drug Discov Devel. 2001. PMID: 12825458 Review.
• Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades?

  Abdollahi E, Momtazi AA, Johnston TP, Sahebkar A. Abdollahi E, et al. J Cell Physiol. 2018 Feb;233(2):830-848. doi: 10.1002/jcp.25778. Epub 2017 Mar 31. J Cell Physiol. 2018. PMID: 28059453 Review.
• Cyclooxygenase 2 controversy: thoughts on the process of discovery, development, and assessment of benefit and risk of therapies for chronic immunoinflammatory diseases of uncertain autoimmune etiology.

  Furst DE, Khanna D, Paulus HE. Furst DE, et al. Arthritis Rheum. 2006 Oct 15;55(5):683-6. doi: 10.1002/art.22240. Arthritis Rheum. 2006. PMID: 17013849 No abstract available.